Skip to Main Content

Blog Posts

Blog Post
Oct. 23, 2020

National Institutes of Health Funding Powers Wistar Science in 2020

Approaching the end of the year, Wistar takes stock of its federal funding performance.

During the 2020 fiscal year of the National Institutes of Health (NIH) — the U.S. government agency that supports biomedical research, it funded Wistar research by granting more than $43M in existing and newly awarded grants.

Blog Post
Oct. 8, 2020

A Life at the Intersection of Music, Biotechnology and Business

A conversation with Anne Schoemaker about her vision to sponsor The Wistar-Schoemaker International Postdoctoral Fellowship, a partnership launched in 2019 by Wistar and Leiden University Medical Center (LUMC) in the Netherlands to bring LUMC graduates to Wistar for for postdoctoral training. 

Blog Post
Jul. 29, 2020

New Research Highlights a Rare Gene Mutation Linked to Cancer Risk in the Ashkenazi Jewish Population

Dr. Maureen  Murphy, Ira Brind Professor and program leader of the Molecular & Cellular Oncogenesis Program of The Wistar Institute Cancer Center, has been investigating the importance of inherited mutations in the gene encoding p53 tumor suppressor protein to determine cancer susceptibility in people of African descent and people of Ashkenazi Jewish descent, for the past twenty-two years.